UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure

Ophthalmology (Rochester, Minn.), 2015-02, Vol.122 (2), p.302-307

2015

Volltextzugriff (PDF)

A new system, the LipiFlow, for the treatment of meibomian gland dysfunction

Cornea, 2012-04, Vol.31 (4), p.396

2012

Volltextzugriff (PDF)

Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring

Ophthalmology (Rochester, Minn.), 2017-10, Vol.124 (10), p.1565-1566

2017

Volltextzugriff (PDF)

Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy

JAMA network open, 2021-11, Vol.4 (11), p.e2134254-e2134254

2021

Volltextzugriff (PDF)

Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial

BMC ophthalmology, 2014-11, Vol.14 (1), p.151-151, Article 151

2014

Volltextzugriff (PDF)

Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.79-91

2021

Volltextzugriff (PDF)

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.669-681

2017

Volltextzugriff (PDF)

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004

Clinical ophthalmology (Auckland, N.Z.), 2012-01, Vol.6 (default), p.525-531

2012

Volltextzugriff (PDF)

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial

Survey of ophthalmology, 2004-03, Vol.49 (2), p.S26-S35

2004

Volltextzugriff (PDF)

Duration of IOP Reduction With Travoprost BAK-free Solution

Journal of glaucoma, 2008-04, Vol.17 (3), p.217-222

2008

Volltextzugriff (PDF)

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure

Clinical therapeutics, 2004, Vol.26 (1), p.84-91

2004

Volltextzugriff (PDF)

A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: A three-month, multicenter, randomized, double-masked, parallel-group trial

Clinical therapeutics, 2001-12, Vol.23 (12), p.1969-1983

2001

Volltextzugriff (PDF)

Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma

American journal of ophthalmology, 1999-02, Vol.127 (2), p.142-147

1999

Volltextzugriff (PDF)

Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial

Archives of ophthalmology (1960), 2006-09, Vol.124 (9), p.1230

2006

Volltextzugriff (PDF)

Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost

American journal of ophthalmology, 1999-12, Vol.128 (6), p.692-696

1999

Volltextzugriff (PDF)

24-hour IOP control with Once-daily bimatoprost, timolol gel-forming solution, or latanoprost: A 1-month, randomized, comparative clinical trial: Advances in the medical management of glaucoma: Comparing the new glaucoma medications

Survey of ophthalmology, 2004, Vol.49, p.S26-S35

2004

Volltextzugriff (PDF)

The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C

Ophthalmic surgery and lasers, 1998-07, Vol.29 (7), p.562

1998

Volltextzugriff (PDF)

Timolol Hemihydrate vs Timolol Maleate to Treat Ocular Hypertension and Open-Angle Glaucoma

American journal of ophthalmology, 1996-05, Vol.121 (5), p.522-528

1996

Volltextzugriff (PDF)

24-hour IOP control key to minimizing glaucoma progression

Ophthalmology Times, 2008-09, Vol.33 (17), p.25

2008

Volltextzugriff (PDF)

24-hour IOP control key to minimizing glaucoma progression: physicians should look to data as important consideration in selecting glaucoma therapy

Ophthalmology times, 2008-09, Vol.33 (17), p.25

2008

Volltextzugriff (PDF)

Artificial Intelligence Detection of Diabetic Retinopathy

Ophthalmology science (Online), 2023-03, Vol.3 (1), p.100228, Article 100228

2023

Volltextzugriff (PDF)

Bimatoprost/Timolol Fixed Combination: A 3-month Double-masked, Randomized Parallel Comparison to Its Individual Components in Patients With Glaucoma or Ocular Hypertension

Journal of glaucoma, 2008-04, Vol.17 (3), p.211-216

2008

Volltextzugriff (PDF)

Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis

American journal of ophthalmology, 2003-12, Vol.136 (6), p.1097-1105

2003

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)
magazinearticle
(1)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Ophthalmology
(19)
Science & Technology
(19)
Humans
(16)
Female
(15)
Male
(14)
Aged
(13)
Middle Aged
(13)
Double-Blind Method
(12)
Glaucoma, Open-Angle - Drug Therapy
(12)
Ocular Hypertension - Drug Therapy
(11)
Adult
(10)
Glaucoma
(10)
Aged, 80 And Over
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Prospective Studies
(9)
Intraocular Pressure
(8)
Intraocular Pressure - Drug Effects
(8)
Antihypertensive Agents - Adverse Effects
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure

A new system, the LipiFlow, for the treatment of meibomian gland dysfunction

Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring

Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy

Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial

Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial

Duration of IOP Reduction With Travoprost BAK-free Solution

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure

A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: A three-month, multicenter, randomized, double-masked, parallel-group trial

Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma

Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial

Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost

24-hour IOP control with Once-daily bimatoprost, timolol gel-forming solution, or latanoprost: A 1-month, randomized, comparative clinical trial: Advances in the medical management of glaucoma: Comparing the new glaucoma medications

The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C

Timolol Hemihydrate vs Timolol Maleate to Treat Ocular Hypertension and Open-Angle Glaucoma

24-hour IOP control key to minimizing glaucoma progression

24-hour IOP control key to minimizing glaucoma progression: physicians should look to data as important consideration in selecting glaucoma therapy

Artificial Intelligence Detection of Diabetic Retinopathy

Bimatoprost/Timolol Fixed Combination: A 3-month Double-masked, Randomized Parallel Comparison to Its Individual Components in Patients With Glaucoma or Ocular Hypertension

Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis

Suchergebnisse filtern